Specific Biomarker Level and Function Outcome Changes in Treatment of Patients with Frozen Shoulder Using Dextrose Prolotherapy Injection
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32870
Specific Biomarker Level and Function Outcome Changes in Treatment of Patients with Frozen Shoulder Using Dextrose Prolotherapy Injection

Authors: Nuralam Sam, Irawan Yusuf, Irfan Idris, Endi Adnan

Abstract:

Frozen shoulder (FS) is an insidious, painful condition caused by an inflammatory condition that causes fibrosis of the glenohumeral joint capsule, which causes progressive stiffness and restriction of the active and passive range of motion (ROM) of the shoulder. The studies of FS are still limited. This single-blinded randomized controlled trial involved participants with FS. The study participants were divided into two groups. The Prolotherapy group was the study group, and the Normal Saline (NS) group was the control group. Both groups were given injections at weeks 0, 2, 4, and 6. Matrix Metalloproteinase-1 (MMP-1) and Tissue Inhibitor Metalloproteinase-1 (TIMP-1) were measured at week six and week 12 after the last injection. The Disabilities of The Arm, Shoulder, and Hand (DASH) Score and ROM were measured at weeks 0, 2, 4, and 6 before and after injection and week 12. Comparative analysis was performed using repeated measures Paired T-Test, and data processing to assess correlation was using ANOVA. The result showed a significant decrease in The Disability of the Arm, Shoulder, and Hand (DASH) score in prolotherapy injection patients in each measurement week (p < 0.05). While the measurement of ROM, each direction of shoulder motion showed a significant difference in average each week, from week 0 to week 6 (p < 0.05). Dextrose prolotherapy injection results significantly improved the functional outcome of the shoulder joint and ROM. They did not show significant results in assessing the specific biomarker, MMP-1, and TIMP-1, in tissue repair. This study suggests an alternative to injection prolotherapy in FS patients; it has minimal adverse effects and is efficient in time and cost.

Keywords: Frozen Shoulder, ROM, DASH Score, prolotherapy, MMP-1, TIMP-1.

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 407

References:


[1] Hubbard MJ, Hildebrand BA, Battafarano MM, Battafarano DF. (2018). Common Soft Tissue Musculoskeletal Pain Disorders. Prim Care. Jun; 45(2):289-303. (PubMed).
[2] Joseph D. Zuckerman; Andrew Rokito (2011). Frozen shoulder: a consensus definition, 20(2), 0–325. doi:10.1016/j.jse.2010.07.008
[3] Cho, C.-H., Song, K.-S., Kim, B.-S., Kim, D. H., & Lho, Y.-M. (2018). Biological Aspect of Pathophysiology for Frozen Shoulder. BioMed Research International, 2018, 1–8. doi:10.1155/2018/7274517
[4] Lubis, A. (2013). Matrix metalloproteinase, tissue inhibitor of metalloproteinase and transforming growth factor-beta 1 in frozen shoulder, and their changes as response to intensive stretching and supervised neglect exercise. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 18. doi : 10.1007/s00776-013-0387-0
[5] Kim, Y.-S., Kim, J.-M., Lee, Y.-G., Hong, O.-K., Kwon, H.-S., & Ji, J.-H. (2013). Intercellular Adhesion Molecule-1 (ICAM-1, CD54) Is Increased in Adhesive Capsulitis. The Journal of Bone and Joint Surgery-American Volume, 95(4), e18–1– 8. doi:10.2106/jbjs.k.00525
[6] Lee, H. V.; Lee, S. J.; Nazarian, A.; Rodriguez, E. K. (2016). Adhesive capsulitis of the shoulder: review of pathophysiology and current clinical treatments. Shoulder & Elbow, 9(2), 75-84. doi:10.1177/1758573216676786.
[7] Xiao RC, DeAngelis JP, Smith CC, Ramappa AJ. (2017). Evaluating Nonoperative Treatments for Adhesive Capsulitis. WINTERJ Surg Orthop Adv. 26(4):193-199.
[8] Zreik NH, Malik RA, Charalambous CP. (2016). Adhesive capsulitis of the shoulder and diabetes: a metaanalysis of prevalence. Muscles Ligaments Tendons J; 6:26.
[9] Nasiri A., Jahromi M., Vafei M. A., Parvin R., Fakheri M. S., Sadeghi S. (2021). Comparison of the Effectiveness of Ultrasound‑Guided Prolotherapy in Supraspinatus Tendon with Ultrasound‑Guided Corticosteroid Injection of Subacromial Subdeltoid Bursa in Rotator Cuff‑Related Shoulder Pain: A Clinical Trial Study. Advance Biomed Research, 10 (12). doi: 10.4103/abr.abr_181_20
[10] Robinson, D. M., Eng, C., Makovitch, S., Rothenberg, J. B., DeLuca, S., Douglas, S., … Borg-Stein, J. (2021). Non-operative orthobiologic use for rotator cuff disorders and glenohumeral osteoarthritis: A systematic review. Journal of Back and Musculoskeletal Rehabilitation, 34(1), 17–32. doi:10.3233/bmr-201844
[11] Bertrand, H., Reeves, K. D., Bennett, C. J., Bicknell, S., & Cheng, A.-L. (2016). Dextrose Prolotherapy Versus Control Injections in Painful Rotator Cuff Tendinopathy. Archives of Physical Medicine and Rehabilitation, 97(1), 17–25. doi:10.1016/j.apmr.2015.08.412
[12] Lin, C.-L., Huang, C.-C., & Huang, S.-W. (2019). Effects of hypertonic dextrose injection in chronic supraspinatus tendinopathy of the shoulder: a randomized placebo-controlled trial. European Journal of Physical and Rehabilitation Medicine, 55(4). doi:10.23736/s1973-9087.18.05379-0
[13] Waluyo, Y., Budu, Bukhari, A., Adnan, E., Darjanti Haryadi, R., Idris, I., Hamid, F., Usman, A., Johan, M. P., & Zainuddin, A. A. (2021). Changes in levels of cartilage oligomeric proteinase and urinary C-terminal telopeptide of type II collagen in subjects with knee osteoarthritis after dextrose prolotherapy: A randomized controlled trial. Journal of Rehabilitation Medicine, 53(5). https://doi.org/10.2340/16501977-2835